The Critical Disclaimer First
There is no FDA-approved oral form of tirzepatide. The only FDA-approved tirzepatide products are injectable: Mounjaro (for type 2 diabetes) and Zepbound KwikPen (for weight management). Every "oral tirzepatide" product currently on the market is a compounded formulation — prepared by 503A pharmacies, not FDA-reviewed as a finished product.
This distinction matters because oral tirzepatide formulations have not been studied in the same controlled clinical trials that demonstrated injectable tirzepatide's efficacy. The bioavailability data for compounded oral tirzepatide formats is limited, and patient outcomes may vary from what the injectable trials showed.
⚠️ Compounded oral tirzepatide is NOT the same as an FDA-approved oral tirzepatide pill. No such FDA-approved product exists. All oral tirzepatide currently available is compounded by 503A pharmacies and has not been individually reviewed by the FDA for safety, effectiveness, or quality.
Providers Offering Oral Tirzepatide
Despite the regulatory caveats, several telehealth providers offer compounded oral tirzepatide in various formats. Here is the current pricing landscape:
| Provider | Format | Monthly Price | Dose Range |
|---|---|---|---|
| Telos Rx | Oral tirzepatide | From $49/mo (12-mo plan) | Provider-determined |
| MadeMed | Oral tirzepatide | Contact | Provider-determined |
Format Options Explained
Sublingual Drops
Liquid tirzepatide placed under the tongue for absorption through the sublingual mucosa. This route partially bypasses GI degradation, offering higher bioavailability than a swallowed tablet. Typically administered daily. Requires holding the liquid under the tongue for 60–90 seconds before swallowing.
Dissolving Troches
Compounded lozenges that dissolve in the cheek (buccal absorption) or under the tongue. Similar absorption mechanism to sublingual drops with the convenience of a solid dosage form. No water needed. Typically daily dosing.
Tablets
Oral tablets swallowed and absorbed through the GI tract. This is the simplest format but has the lowest bioavailability for peptide medications — the GI tract degrades a significant portion of the tirzepatide before absorption. Prescribers compensate with higher doses.
💡 The oral GLP-1 pill generating the most headlines in 2026 is orforglipron (brand name Foundayo) — which is NOT tirzepatide. Orforglipron is a different, non-peptide molecule that activates the GLP-1 receptor and is designed for oral bioavailability. It is FDA-approved. Compounded oral tirzepatide is a different product entirely.
The Price vs. Injectable Comparison
| Format | Typical Price Range | Annual Cost | Needle-Free? | FDA Status |
|---|---|---|---|---|
| Compounded oral tirz | $49–$299/mo | $588–$3,588 | ✅ Yes | Not approved |
| Compounded injectable tirz | $133–$399/mo | $1,596–$4,788 | ❌ No | Not approved |
| Zepbound KwikPen (brand) | $299–$449/mo | $3,588–$5,388 | ❌ No | ✅ Approved |
| Foundayo (oral, different drug) | $149–$299/mo | $1,788–$3,588 | ✅ Yes | ✅ Approved |
Compounded oral tirzepatide occupies a price range that overlaps with injectable alternatives. The value proposition is primarily convenience (no needles) rather than cost savings — though commitment-plan pricing at providers like Telos Rx can push the monthly cost well below injectable alternatives.
Questions to Ask Before Choosing Oral Tirzepatide
- Which 503A pharmacy compounds your oral tirzepatide? The pharmacy should be named, state-licensed, and verifiable. If the provider will not name the pharmacy, that is a red flag.
- What is the bioavailability of this specific formulation? Reputable providers should be transparent about expected absorption rates. Vague answers like "comparable to injection" are not supported by published data.
- How was the dose determined? Since oral tirzepatide has no FDA-approved dosing guide, your prescriber should explain the clinical reasoning behind your starting dose and titration plan.
- What is the quality testing protocol? Ask whether the compounding pharmacy performs potency and content uniformity testing on oral tirzepatide batches.
- Have you considered Foundayo instead? If needle avoidance is your primary motivation, Foundayo (oral orforglipron) is an FDA-approved oral option that activates the GLP-1 receptor — without the regulatory uncertainty of compounded oral tirzepatide.
Sesame Care prescribes FDA-approved brand-name medications only, including Foundayo, for patients who prefer an oral format with full FDA approval.
The Bottom Line
Compounded oral tirzepatide is a real product available from real providers — but it comes with more regulatory and clinical uncertainty than any other GLP-1 option on the market. There is no FDA-approved version, no published clinical trial data on compounded oral formulations, and limited bioavailability data. For needle-averse patients, it is one option — but Foundayo (FDA-approved oral GLP-1) and injectable semaglutide at budget providers may offer better-established paths at comparable or lower costs.
⚠️ No oral tirzepatide product is FDA-approved. Compounded oral tirzepatide is prepared by 503A pharmacies and has not been reviewed by the FDA for safety, effectiveness, or quality. Always discuss oral GLP-1 options with a licensed clinician who can advise on the most appropriate format for your clinical situation.